Izun Pharmaceuticals

About:

Izun Pharmaceuticals develops non-steroidal topical oral anti-inflammatory therapies for periodontal treatments.

Twitter/X: izunpharma

Description:

Izun Pharmaceuticals is a biopharmaceutical company with a product portfolio of powerful non-steroidal topical oral anti-inflammatory therapies with superior efficacy and safety to current periodontal treatments.

Total Funding Amount:

$5.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

New York, New York, United States

Founded Date:

2000-04-04

Contact Email:

info(AT)izunpharma.com

Founders:

William Z. Levine

Number of Employees:

11-50

Last Funding Date:

2014-11-13

IPO Status:

Private

Industries: